Why Rapt Therapeutics Stock Soared Today
Source: Motley Fool
2026-01-20 17:30:07 ET
Shares of Rapt Therapeutics (NASDAQ: RAPT) surged on Tuesday after the immunology specialist struck a deal to be acquired by British pharmaceutical leader GSK (NYSE: GSK) for $2.2 billion.
By the close of trading, Rapt's stock price was up more than 60%.
Image source: Getty Images.
RAPT Therapeutics Inc.
NASDAQ: RAPT
RAPT Trading
0.07% G/L:
$57.995 Last:
8,357,151 Volume:
$57.98 Open:
RAPT Latest News
March 15, 2026 06:20:40 pm
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
February 25, 2026 03:19:51 pm
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges
February 11, 2026 08:02:00 pm
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
RAPT Stock Data
$1,601,411,235
19,597,128
0.05%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
